News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
153,957 Results
Type
Article (8492)
Company Profile (42)
Press Release (145423)
Multimedia
Podcasts (9)
Webinars (3)
Section
Business (45610)
Career Advice (143)
Deals (8009)
Drug Delivery (32)
Drug Development (20773)
Employer Resources (12)
FDA (4443)
Job Trends (2714)
News (80455)
Policy (8998)
Tag
Academia (503)
Accelerated approval (5)
Adcomms (7)
Allergies (38)
Alliances (15740)
ALS (22)
Alzheimer's disease (361)
Antibody-drug conjugate (ADC) (63)
Approvals (4439)
Artificial intelligence (72)
Autoimmune disease (12)
Automation (6)
Bankruptcy (28)
Best Places to Work (2191)
BIOSECURE Act (16)
Biosimilars (99)
Biotechnology (31)
Bladder cancer (39)
Brain cancer (7)
Breast cancer (87)
Cancer (831)
Cardiovascular disease (37)
Career advice (125)
Career pathing (3)
CAR-T (33)
CDC (9)
Cell therapy (134)
Cervical cancer (4)
Clinical research (17514)
Collaboration (350)
Compensation (72)
Complete response letters (13)
COVID-19 (696)
CRISPR (9)
C-suite (86)
Cystic fibrosis (18)
Data (850)
Denatured (2)
Depression (12)
Diabetes (61)
Diagnostics (1124)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (45)
Drug pricing (35)
Drug shortages (1)
Duchenne muscular dystrophy (45)
Earnings (16093)
Editorial (9)
Employer branding (3)
Employer resources (10)
Events (18204)
Executive appointments (192)
FDA (5023)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (246)
Gene editing (32)
Generative AI (7)
Gene therapy (123)
GLP-1 (157)
Government (1494)
Grass and pollen (2)
Guidances (50)
Healthcare (2895)
Huntington's disease (7)
IgA nephropathy (10)
Immunology and inflammation (61)
Immuno-oncology (3)
Indications (15)
Infectious disease (751)
Inflammatory bowel disease (61)
Inflation Reduction Act (6)
Influenza (28)
Intellectual property (31)
Interviews (11)
IPO (3221)
IRA (15)
Job creations (605)
Job search strategy (121)
Kidney cancer (3)
Labor market (6)
Layoffs (65)
Leadership (1)
Legal (1453)
Liver cancer (29)
Lung cancer (131)
Lymphoma (60)
Machine learning (3)
Management (2)
Manufacturing (168)
MASH (23)
Medical device (2199)
Medtech (2201)
Mergers & acquisitions (5004)
Metabolic disorders (153)
Multiple sclerosis (26)
NASH (3)
Neurodegenerative disease (27)
Neuropsychiatric disorders (1)
Neuroscience (512)
NextGen: Class of 2025 (897)
Non-profit (413)
Now hiring (12)
Obesity (61)
Opinion (51)
Ovarian cancer (41)
Pain (14)
Pancreatic cancer (29)
Parkinson's disease (38)
Partnered (5)
Patents (66)
Patient recruitment (35)
Peanut (22)
People (12305)
Pharmaceutical (14)
Pharmacy benefit managers (4)
Phase I (5424)
Phase II (7335)
Phase III (6413)
Pipeline (560)
Policy (85)
Postmarket research (514)
Preclinical (2072)
Press Release (66)
Prostate cancer (33)
Psychedelics (6)
Radiopharmaceuticals (61)
Rare diseases (131)
Real estate (1412)
Recruiting (4)
Regulatory (6995)
Reports (12)
Research institute (463)
Resumes & cover letters (12)
Rett syndrome (1)
RNA editing (2)
RSV (15)
Schizophrenia (23)
Series A (52)
Series B (26)
Service/supplier (4)
Sickle cell disease (11)
Special edition (4)
Spinal muscular atrophy (25)
Sponsored (10)
Startups (938)
State (1)
Stomach cancer (5)
Supply chain (17)
Tariffs (15)
The Weekly (7)
Vaccines (242)
Venture capital (11)
Weight loss (20)
Women's health (4)
Date
Today (17)
Last 7 days (94)
Last 30 days (500)
Last 365 days (8078)
2025 (4431)
2024 (8906)
2023 (9902)
2022 (14512)
2021 (14559)
2020 (13047)
2019 (9072)
2018 (7026)
2017 (8087)
2016 (7297)
2015 (8785)
2014 (6389)
2013 (5138)
2012 (5445)
2011 (5710)
2010 (4996)
Location
Africa (163)
Alabama (17)
Alaska (1)
Arizona (22)
Arkansas (2)
Asia (25523)
Australia (3065)
California (1791)
Canada (507)
China (378)
Colorado (40)
Connecticut (47)
Delaware (61)
Europe (24537)
Florida (219)
Georgia (33)
Idaho (13)
Illinois (86)
India (16)
Indiana (47)
Iowa (7)
Japan (137)
Kansas (9)
Kentucky (11)
Louisiana (3)
Maine (9)
Maryland (408)
Massachusetts (1255)
Michigan (31)
Minnesota (83)
Mississippi (2)
Missouri (20)
Montana (5)
Nebraska (2)
Nevada (6)
New Hampshire (3)
New Jersey (741)
New Mexico (4)
New York (518)
North Carolina (271)
North Dakota (9)
Northern California (742)
Ohio (47)
Oklahoma (7)
Oregon (4)
Pennsylvania (286)
Puerto Rico (1)
Rhode Island (6)
South America (228)
South Carolina (3)
Southern California (770)
Tennessee (4)
Texas (220)
United States (6376)
Utah (41)
Virginia (52)
Washington D.C. (9)
Washington State (130)
West Virginia (1)
Wisconsin (16)
153,957 Results for "cobra biologics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Faron Pharmaceuticals Ltd: Director/PCA Dealing
July 1, 2025
·
3 min read
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to share additional data from its diagnostic 64Cu-SAR-bisPSMA trial, COBRA.
March 8, 2024
·
11 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Press Releases
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
June 23, 2025
·
1 min read
Press Releases
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Company Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025
June 12, 2025
·
6 min read
Press Releases
Restore Medical LTD secures $23M to Advance Breakthrough Medical Device for Heart Failure Therapy
July 8, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options
May 15, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)
July 8, 2025
·
8 min read
1 of 15,396
Next
